VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Clinical trials for VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE explained in plain language.
Never miss a new study
Get alerted when new VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE trials appear
Sign up with your email to follow new studies for VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can this pill cool down menopause hot flashes?
Symptom relief CompletedThis study tested whether a dietary supplement could reduce hot flashes and other menopause symptoms in women aged 40-70. All 112 participants took the supplement daily for 4 weeks, with an option to continue for 8 more weeks. Researchers tracked changes in symptom frequency and …
Matched conditions: VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Phase: NA • Sponsor: Bonafide Health • Aim: Symptom relief
Last updated Apr 01, 2026 22:11 UTC
-
New drug shows promise for taming menopause hot flashes
Symptom relief CompletedThis study tested whether a new medication called elinzanetant could reduce hot flashes in women after menopause. Researchers compared elinzanetant against a placebo (dummy pill) in 396 postmenopausal women who experienced frequent moderate-to-severe hot flashes. Participants tra…
Matched conditions: VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Mar 30, 2026 14:41 UTC
-
New drug shows promise in taming Menopause's most common symptom
Symptom relief CompletedThis study tested whether a new drug called elinzanetant could reduce hot flashes in postmenopausal women. Researchers compared it to a placebo in 628 women over 52 weeks, tracking how many hot flashes they had and how severe they were. The study also looked at whether the treatm…
Matched conditions: VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
New drug shows promise in taming Menopause's most common symptom
Symptom relief CompletedThis study tested whether a new drug called elinzanetant could safely reduce the number and severity of hot flashes in women after menopause. 400 postmenopausal women with frequent moderate-to-severe hot flashes took either elinzanetant or a placebo pill daily for up to 26 weeks.…
Matched conditions: VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC